New obesity drug aims to curb appetite and boost metabolism
NCT ID NCT06313528
Summary
This early-stage study tested whether a new drug, LY3437943, could help people with obesity eat fewer calories and use energy differently while dieting. It compared the drug to a placebo in 85 participants over about six months. The main goal was to see if the drug changed how much people ate at meals and how their bodies burned energy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32804, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Conditions
Explore the condition pages connected to this study.